Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
oleh: Lisa Trieu, Douglas C. Proops, Shama D. Ahuja
| Format: | Article |
|---|---|
| Diterbitkan: | Centers for Disease Control and Prevention 2015-03-01 |
Deskripsi
Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB–positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.